A small family business with large holdings

How promising companies
become successful.

Schörling’s role as an active owner is to create opportunities for companies to develop and become best in class. We believe in a long-term perspective, being cost-conscious, and building close relationships. And last, but not least, we believe in having focus on results.

→

AAK
Absolent
Anticimex
Assa Abloy
Beijer Ref
Greenbridge
Hexagon
Hexpol
Nibe
Octave
Securitas

The companies we invest in

Schörling is an active owner specializing in industrial businesses with roots in Scandinavia. These companies are globally widespread and most of their sales take place outside of Sweden. They all share two similarities: great development potential from the beginning, and growth over time into world leaders in their respective niches.

Our Holdings

→

The relationships we build

To Schörling, people are and have always been the most important factor. In our team, our network and the companies we invest in. We surround ourselves with individuals with different competencies, experiences and personalities. Together, we share the same values and are driven by our ambition to develop sound businesses that become best in class. The Schörling board consists of a group of carefully selected people who all contribute with their substantial and diverse experience. They know our companies inside out.

About Us

→

The Schörling Foundation

The Schörling Foundation was instituted by the Schörling family in 2014. The Foundation is run without profit and has its financial base in a donation made by Melker Schörling, the founder of the company.

The Foundation’s purpose is to promote scientific education and research. This is done by supporting current and urgent projects run by institutes or individual researchers. In addition, the Foundation supports projects, organizations and individuals who encourage the development of children and young people.

"The Swedish FTD Initiative" is a research project founded and supported by the Foundation. The goal is to strengthen the collaboration within research so that one day effective treatment against FTD (frontotemporal dementia) will be offered. Two professors from Karolinska Institutet and two professors from KTH have together had the opportunity to build a consortium for research on the disease over several years.

In the beginning of 2022, The Schörling Foundation decided to grant funding to Karolinska Institutet, Department of Molecular Medicine and Surgery, Research Group Thoracic Surgery. The purpose of the donation is to enforce the devlopment of cardiothoracic surgical technology and methodology and the related reserach by the group.

News & Reports

All News & Reports

→

CEO and MD, Gerteric Lindquist, comments on the Interim Report 2, 2026

Nibe

—

2026

Continued good growth and further improvement in profitability

NIBE Industrier AB (publ), Interim Report 2, 2026

Nibe

—

2026

Continued good growth and further improvement in profitability

Hexagon’s shareholding in Hangzhou Yushu Technology Co., Ltd (Unitree Technologies)

Hexagon

—

2026

Following the Initial Public Offering (IPO) of Unitree Technologies, Hexagon expects to record a gain in its third quarter results on the revaluation of its shareholding, which represents 1.198% of the Unitree’s issued share capital. The gain will be calculated on the closing share price on 30 September 2026. Based on today's closing price, the gain would be approximately €500m. Any gain will be recorded as a non-cash Item Affecting Comparability (IAC) in Hexagon's accounts. The shares are subject to a 12-month lock-up period from today’s date. For further information, please contact: